Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ)
CNY 5.52
(-0.18%)
CNY 5.52
(-0.18%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 239.64 Million CNY | -28.89% |
| 2022 | 251.73 Million CNY | 14.18% |
| 2021 | 220.46 Million CNY | 9.22% |
| 2020 | 201.86 Million CNY | -10.02% |
| 2019 | 224.32 Million CNY | 3.96% |
| 2018 | 215.78 Million CNY | 17.96% |
| 2017 | 182.92 Million CNY | 3.76% |
| 2016 | 176.29 Million CNY | 2.82% |
| 2015 | 171.46 Million CNY | 14.45% |
| 2014 | 149.81 Million CNY | 55.47% |
| 2013 | 96.35 Million CNY | 14.89% |
| 2012 | 83.86 Million CNY | 27.32% |
| 2011 | 65.87 Million CNY | 17.97% |
| 2010 | 55.84 Million CNY | 50.94% |
| 2009 | 36.99 Million CNY | 36.51% |
| 2008 | 27.1 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 39.6 Million CNY | -24.18% |
| 2024 Q3 | 51.53 Million CNY | 15.72% |
| 2024 Q1 | 52.23 Million CNY | -10.96% |
| 2023 Q1 | 51.29 Million CNY | -27.15% |
| 2023 Q4 | 58.66 Million CNY | 5.84% |
| 2023 FY | 179 Million CNY | -28.89% |
| 2023 Q3 | 55.43 Million CNY | -0.59% |
| 2023 Q2 | 55.75 Million CNY | 8.7% |
| 2022 FY | 251.73 Million CNY | 14.18% |
| 2022 Q3 | 67.07 Million CNY | 7.61% |
| 2022 Q4 | 70.41 Million CNY | 4.98% |
| 2022 Q1 | 51.92 Million CNY | -18.08% |
| 2022 Q2 | 62.32 Million CNY | 20.04% |
| 2021 Q4 | 63.38 Million CNY | 19.43% |
| 2021 Q1 | 49.12 Million CNY | -23.88% |
| 2021 Q2 | 54.88 Million CNY | 11.72% |
| 2021 Q3 | 53.07 Million CNY | -3.3% |
| 2021 FY | 220.46 Million CNY | 9.22% |
| 2020 FY | 201.86 Million CNY | -10.02% |
| 2020 Q4 | 64.53 Million CNY | 26.96% |
| 2020 Q3 | 50.83 Million CNY | 13.28% |
| 2020 Q2 | 44.87 Million CNY | 7.82% |
| 2020 Q1 | 41.61 Million CNY | -36.51% |
| 2019 FY | 224.32 Million CNY | 3.96% |
| 2019 Q4 | 65.55 Million CNY | 10.26% |
| 2019 Q3 | 59.45 Million CNY | 17.71% |
| 2019 Q2 | 50.5 Million CNY | 3.48% |
| 2019 Q1 | 48.8 Million CNY | -26.52% |
| 2018 Q2 | 52.05 Million CNY | 13.16% |
| 2018 Q1 | 46 Million CNY | -25.19% |
| 2018 Q3 | 51.29 Million CNY | -1.46% |
| 2018 FY | 215.78 Million CNY | 17.96% |
| 2018 Q4 | 66.42 Million CNY | 29.49% |
| 2017 Q2 | 38.77 Million CNY | -5.0% |
| 2017 Q4 | 61.49 Million CNY | 46.94% |
| 2017 FY | 182.92 Million CNY | 3.76% |
| 2017 Q1 | 40.81 Million CNY | -21.78% |
| 2017 Q3 | 41.85 Million CNY | 7.94% |
| 2016 Q2 | 38.92 Million CNY | -4.04% |
| 2016 Q3 | 44.63 Million CNY | 14.69% |
| 2016 Q4 | 52.17 Million CNY | 16.89% |
| 2016 FY | 176.29 Million CNY | 2.82% |
| 2016 Q1 | 40.55 Million CNY | -14.63% |
| 2015 Q2 | 31.54 Million CNY | -33.01% |
| 2015 Q4 | 47.5 Million CNY | 4.85% |
| 2015 FY | 171.46 Million CNY | 14.45% |
| 2015 Q3 | 45.31 Million CNY | 43.64% |
| 2015 Q1 | 47.09 Million CNY | -17.22% |
| 2014 FY | 149.81 Million CNY | 55.47% |
| 2014 Q4 | 56.89 Million CNY | 65.11% |
| 2014 Q3 | 34.45 Million CNY | 20.78% |
| 2014 Q2 | 28.52 Million CNY | -4.7% |
| 2014 Q1 | 29.93 Million CNY | 9.31% |
| 2013 Q3 | 26.17 Million CNY | 24.57% |
| 2013 FY | 96.35 Million CNY | 14.89% |
| 2013 Q2 | 21.01 Million CNY | -3.51% |
| 2013 Q4 | 27.38 Million CNY | 4.62% |
| 2013 Q1 | 21.77 Million CNY | -17.51% |
| 2012 Q1 | 18.25 Million CNY | -13.83% |
| 2012 Q2 | 18.01 Million CNY | -1.29% |
| 2012 FY | 83.86 Million CNY | 27.32% |
| 2012 Q3 | 21.19 Million CNY | 17.64% |
| 2012 Q4 | 26.4 Million CNY | 24.55% |
| 2011 Q1 | 13.49 Million CNY | 0.0% |
| 2011 Q3 | 15.15 Million CNY | -5.58% |
| 2011 Q2 | 16.04 Million CNY | 18.95% |
| 2011 FY | 65.87 Million CNY | 17.97% |
| 2011 Q4 | 21.18 Million CNY | 39.8% |
| 2010 FY | 55.84 Million CNY | 50.94% |
| 2009 FY | 36.99 Million CNY | 36.51% |
| 2008 FY | 27.1 Million CNY | 0.0% |